SAN DIEGO, CA (February 5, 2015) – PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has signed a non-exclusive agreement with All American Chemical Company Inc. to distribute PURE® Hard Surface disinfectant to its network of more than 175+ food and beverage manufacturers/processors. The arrangement broadens and deepens the sales reach for PURE’s powerful antimicrobial products.
All American Chemical Company Inc. is a leading, family owned company that has been providing cleaning chemicals, sanitizers, state of the art antimicrobial interventions, and sanitation solutions to the food and beverage industries for over 30 years. All American’s goal is to “keep food safe from factory to fork” by building comprehensive solutions that create safe food and beverage environments.
EVOLUTION FROM CUSTOMER TO DISTRIBUTOR
Impressed with the unparalleled efficacy of the non-toxic SDC antimicrobial after using it last fall, All American Chemical Company Inc. sought to expand beyond using PURE Hard Surface disinfectant and become a distributor for the product.
INCLUSION OF PURE HARD SURFACE IN PROTOCOLS
Having developed a reputation for partnering with customers to solve problems, All American Chemical also provides technology and consulting services and implementation support to retailers and food manufacturers producing private brand products.
Sam J. Saltzman, President of All American Chemical, said, “We believe the best way to ensure a safe manufacturing environment for our customers in food and beverage production is to proactively create a holistic food safety culture. We have first-hand experience with the robust efficacy and the ease and safety of using PURE Hard Surface. It is a perfect fit into our tool box of pathogen solutions.”
Hank R. Lambert, CEO of PURE Bioscience, added, “All American Chemical is broadening our products’ reach into a wider range of food manufacturers/processors to which we wouldn’t typically have ready access – providing a path to faster market penetration. We have shipped an initial order, and PURE Hard Surface is already being evaluated by customers through All American Chemical.”
About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s cash position and liquidity requirements; the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company’s PURE Hard Surface disinfectant by SUBWAY® franchisees and the ability to convert successful evaluations into customer orders; the ability of the Company to develop effective new products and receive regulatory approvals of such products, including the required data and regulatory approvals to support the use of its SDC-based technology as a direct food contact processing aid; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q filed on March 4, 2015. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Peter C. Wulff, CFO & COO
PURE Bioscience, Inc.